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Abstract
Background: With the development of information and communication technologies, telemedicine has been
proposed as a way to improve patient management by facilitating access to appropriate diagnosis and treatment.
The Paris Ile de France Regional Health Agency is currently funding a comprehensive program of telemedicine
experiments. This article describes the protocols for the evaluation of the implementation of telemedicine in the
Paris region.
Methods/design: Over 2,500 patients have been included in eight studies addressing the use of telemedicine in
the context of specific diseases or settings. Two projects are randomized controlled trials, while the six other
projects are based on before-after designs (differences in differences studies). Based on the MAST model and the
French national framework, we identified endpoints to assess the impact of telemedicine on five dimensions:
clinical effectiveness, cost-effectiveness, security of the application, patient satisfaction and quality of life and
perception of professionals.
Discussion: Telemedicine encompasses a wide range of services and stakeholders, and thus study protocols must
be tailored to the specific constraints and interests of the users.
Trial registration: NCT02110433 (03/07/2014), NCT02157740 (05/27/2014), NCT02374697 (02/05/2015),
NCT02157727 (05/27/2014), NCT02229279 (08/28/2014), NCT02368769 (02/05/2015), NCT02164747 (NCT02164747),
NCT02309905 (11/27/2014).
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Background
Improving access to care for either specific populations
or specific conditions or diseases is a strategic priority
for the Paris Regional Health Agency (Agence Régionale
de Santé Ile-de-France), which has authority over health
care policy in the capital region of France, with a popula-
tion of 12 million with a budget of €30 billion. The region
has 419 hospitals and 2,000 long term and social care
institutions and a total of 190,000 healthcare professionals.
Its missions cover prevention, health care delivery and
social care.
Telemedicine [1] has been shown to improve the man-
agement of chronic conditions, to improve decision making
in acute situations [2], to compensate for local scarcity of
health care resources [3] and to provide access to rare ex-
pertise [4–6]. In France, it was first legally defined in the
2009 Hospital, Patients, Health and Territories Act and the
2010 Social Security Finance Act. Telemedecine involves
the remote exchange of data between a patient and health
care professionals or between professionals as part of a pa-
tient’s diagnosis and health care management and is limited
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by decree1 to four types of intervention (Table 1), all of
which are under the responsibility of a physician at the
remote site.
A five-year plan with a total budget of €14 million was
established by the Paris Regional Health Agency to fos-
ter the development of telemedicine in two major areas:
promotion of the efficient utilization of health services
in people with chronic illness and long-term conditions
and improvement of access to specialized care in geograph-
ically or socially deprived populations. Chronic illnesses
targeted for telehealth programs were congestive heart
failure, end-stage renal failure, mental disorders and
obesity. Populations were selected on the basis of need
for specialized medical advice or care and access problems
include neonates, nursing home residents and more gen-
erally older people with long-term conditions and social
care needs, patients with acute stroke, inmates with health
needs and surgical patients with suspected tumors.
The deployment of telemedicine interventions followed
a competitive bidding process, and projects were selected
based upon the priorities described above. The telemedi-
cine program was also designed to create multidisciplinary
teams in health and social services and to implement plans
to deliver care or expertise more effectively.
National and international templates for the assessment
of telemedicine projects are currently available (MAST
[7], WSD [8], HAS [9]). All emphasize the need for a
comparative design [10] and acknowledge the trade-off
between methodological requirements to ensure internal
and external validity on the one hand and feasibility, sup-
port of stakeholders and available research funds on the
other. All templates also underscore the importance of
using a multiple endpoint/multiple stakeholder approach.
This approach may be represented by a matrix that com-
bines clusters of endpoints with groups of stakeholders.
We report here on the protocols of ongoing studies se-
lected by the Paris Regional Health Agency to deal more
efficiently with chronic conditions and to reduce social
and geographic inequities in access to care, including the
methodological issues raised by these studies.
Methods/design
The research aim for each of the trials is to assess the
effectiveness and cost-effectiveness of telemonitoring
and teleconsulting in the management of patients with
long-term health conditions, and teleconsulting or tele-
expertise in the management of patients with social or
geographical limitation to care access. The proposed trials
are pragmatic, comparative (randomized or before-after)
and assess the impact of the interventions in the context
of routine delivery of care in the Paris region.
Populations, conditions and settings
Five categories of patients are included in the telemedicine
trials:
1) Community-based adult patients: The telemedicine
trials concern patients suffering from heart failure or
requiring care following knee or hip replacement
surgery for osteoarthritis. These patients need
precise and continuous management with follow-up
visits or care at home.
2) Institutionalized patients: These patients are
dependent elderly persons living in nursing homes
without on-site access to primary and secondary care.
Many consultations currently require medical trans-
portation and the involvement of several healthcare
professionals.
3) Inmates: Prisoner transportation is hazardous and
costly, resulting in a significant lack of and the access
to health care. The first phase of the telemedicine
experiment aims to deliver dermatological expertise,
followed by other specialities once feasibility has been
demonstrated.
4) Neonates: Neonatal ICU patients are frail neonates at
high risk of developing premature retinopathy. While
these patients require expertise to ensure an early
diagnosis, access to specialized paediatric ophthalmology
is limited.
5) Surgical patients needing intraoperative frozen
section analysis and patients with lesions requiring
Table 1 Definition of telemedicine by type of provider and participant (Decree No. 2010–1229 Art.R. 6316–1 of 19 October 2010)
Type of telemedicine Definition On site Remote site
Teleconsulting Remote consultation Patient Physician
Physician(s) (optional)
Health professional(s) (optional)
Tele-expertise Expert advice Physician Physician
Telemonitoring Clinical, radiological or biological data interpretation Patient Physician
Physician(s) (optional)
Health professional(s) (optional)
Teleassistance Medical procedure Physician(s) and/or Physician
Health professional(s)
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complex pathological interpretation: The scarcity of
on-site and specialized pathologists to provide second
opinions prompted the decision to use whole slide
imaging for remote pathological examination.
Over 2,500 patients will be included in the Paris Regional
Health Agency telemedicine trials.
Few exclusion criteria were defined for the studies,
and patients will not be excluded based on the existence
of additional physical co-morbidities.
Interventions
We will assess interventions that fall into three of the four
legal categories of telemedicine in France. Each study site
has separate agreements with technology suppliers, which
were chosen following tender offers by the Paris Regional
Health Agency. No attempt was made to standardize the
technology across study sites.
1) Teleconsulting for institutionalized and community-
based patients.
Two projects aim to evaluate the impact of
teleconsulting for institutionalized patients and one
for community-based patients. Videoconference tools,
allowing real-time, face-to-face remote consultations,
are installed in patient homes, nursing homes and
hospitals.
a) Telemedicine and Geriatrics in the Essonne area
(TLM-TMG91 Clinical Trials NCT02164747):
Prior to the availability of teleconsulting, when a
nursing home resident had a serious health
problem, the patient was transferred to the
reference hospital emergency unit using a medical
transportation vehicle with a high probability that
the patient would remain for more than a few
hours at the hospital. Teleconsulting allows the
caregiver in the patient room to contact a
physician, general practitioner or geriatrician and
provide data via connected medical devices such
as EKGs and blood pressure monitors. The
objective of this unscheduled teleconsulting is to
determine whether the patient needs to be
transferred to the emergency unit or may remain
at the nursing home, with or without new
medications.
b) Teleconsulting and nursing homes (TLM-EVLINE
Clinical Trials NCT02157740): Scheduled
specialized consultations are performed through a
video conference application that allows on-site
consultations instead of transporting the patient for
a physician visit. Like the geriatrics project in the
Essonne area, unscheduled teleconsulting is also
used as a means of determining whether transfer to
an emergency unit is necessary.
c) Teleconsulting and rehabilitation at home after
hip and knee surgical procedures (TLM HAD
Clinical Trials NCT02229279): Patients receive a
videoconference tool at home allowing the
coordinated care physician to perform scheduled
remote consultations, to supervise treatment and
health condition after orthopedic surgery and to
foster the therapeutic education of patients.
2) Tele-expertise for neonates, surgical patients and
inmates.
All three tele-expertise projects focus on imaging
based on picture archiving and transfer.
a) Tele-imaging to evaluate retinopathy of
premature infants (TLM-DITEROP Clinical
Trials NCT02157727): Screening for retinopathy
of premature infants (ROP) involves highly
specialized pediatric ophthalmologists, who are
scarce outside of Paris. Before the recent
availability of tele-expertise, it was difficult for
neonatology units to follow the international
recommendations for ROP screening [11]. When
a specialist was not present on site, the infant was
sent home with an ophtalmologist appointment.
Tele-expertise allows fundus examination to be
performed by a trained nurse, with pictures
uploaded to a secure server and interpreted by
specialized pediatric ophthalmologists.
b) Digital slides and image transfer (TLM-Pathology
Expertise NCT02374697 and TLM-Pathology
Frozen Section NCT02368769): This project is
aimed at performing intraoperative frozen section
analysis offsite in community hospitals with the
goal of obtaining the same diagnostic accuracy as
with original glass slide interpretation. The same
technology is used to obtain second opinions from
specialized pathologists for complex pathological
diagnoses using digital slides uploaded to a
webserver.
c) Teledermatology for inmates (TLM-Teledermatology
Clinical Trials NCT02309905): There is a lack of
dermatologists to treat skin lesions in prisons.
The waiting time for an appointment often
exceeds one month, and the inmate must be
transported by the police to a hospital, with both
the location and the date of transfer kept secret
in order to prevent escapes. Furthermore, the
inmate may not available for various reasons at
that the time of the appointment. The objective
of tele-expertise is to send images of the lesion
to an offsite dermatologist, who can then prescribe
an appropriate treatment for the inmate.
3) Telemonitoring for patients with heart failure
Heart Failure Educational and Follow up Platform
(HELP Clinical Trials NCT02110433): Connected
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devices for patients suffering from severe heart
failure monitor weight, blood pressure and BNP
(Brain Natriuretic Peptide, a biomarker of Heart
Failure) and also provide an educational platform
for patients and relatives. The aim is to reduce the
number of adverse events, including all-cause mortality,
unplanned heart failure-related hospitalizations,
emergency department admissions.
Study designs
Two studies among the eight used the individual random-
ized control trial (RCT) design (Table 2). Nevertheless,
such designs often are neither straightforward nor ethical
to implement, particularly when the professionals in
charge of patient inclusion are not familiar with medical
research procedures.
A more pragmatic approach is the pre-post (before-after)
design, where the addition of a control group reinforces the
validity of the results (controlled before-after or differences
in differences studies) [11]. Four studies used the latter
design, as it allows greater flexibility and produces faster
results while ensuring sufficient level of evidence for
health authorities. Control groups could not be created for
two studies, and thus we used before-after designs without
control groups.
For studies with a control group, four groups will be
identified:
 The intervention group before the implementation
of the telemedicine intervention
 The intervention group during telemedecine
intervention
 The control group before implementation of the
telemedicine intervention
 The control group during the telemedicine
intervention
For studies without a control group, two groups will
be identified:
 The group before the implementation of the
telemedicine intervention
 The group during the telemedecine intervention
Kidholm et al. suggest that an assessment based on
MAST should not be started while the intervention is
still being developed and needs improvement [7]; for that
reason, there will be a gap of several months between
the end of the “before” period and the beginning of the
“after” period.
Data sources
Various sources will be used depending on the design of
the study, including web-based Case Report Forms and
administrative databases, such as the Statutory Health
Insurance national reimbursement database, which includes
dates and costs of all medical transport, consultations and
DRGs for hospital admissions. The objective was to use the
medical information systems available in each setting to
minimize the data collection burden.
Outcomes
1) Clinical effectiveness
Multiple endpoints were defined based on the
particular characteristics of each telemedicine
project:
o Impact on clinical parameters, such as the
WOMAC score [12] (TLM_HAD), will be measured.
o Impact on clinical management, such as the
number of lost to follow-up and time to consultation,
diagnosis, prognosis or therapeutic decision.
2) Resource utilization, cost and cost-effectiveness
Impact on health care services utilization will be
measured when appropriate, particularly in the
telemonitoring and teleconsulting projects. These
endpoints include, for example, the number of
hospitalizations, number of visits to an emergency
department, number of medical transports and
length of stay.
The cost analysis will be performed primarily from a
societal perspective, with valuation of the cost of
hospital stays (including readmissions), emergency
visits, outpatient visits and medical transport.
Payment for telemedicine services has not been
formally established in France, and thus the operating
costs will be valued from the health provider
perspective. These costs include the labor costs
related to operation of the telemedicine intervention,
professional and patient education and training,
investment in equipment, the cost of building
alterations and the call center, where relevant.
The Incremental Cost Effectiveness Ratio (ICER)
will relate the overall costs to the primary endpoint
for each study.
3) Security of the application
We created a registry of all problems that impede
the proper functioning of the telemedicine
interventions, such as unacceptable delays in
obtaining required information and network or
interface issues.
4) Patient Perspective
We will use the WSD SUTAQ questionnaire for
telemonitoring projects [13] during the last month
of follow up. We previously translated that
questionnaire into French following the MAST
methodology: two forward translations from English
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Table 2 The eight telemedicine studies
Project Population Condition Setting Procedures Study design Primary Outcome Measures Sample size
TLM-HAD Patients with total knee
replacement for Osteoarthritis
or hip replacement for
coxarthrosis
After surgery Community Teleconsulting RCT Mean transport duration of
the specialist
154
HELP Chronic heart failure patients Chronic heart failure Community Telemonitoring RCT Composite end point: unplanned
hospitalizations for HF/all-cause
death/non-programmed emergency




Nursing Home Teleconsulting Controlled before-after
study
Number of transports to emergency
services
300
TLM-TMG 91 Elderly Emergencies Nursing Home Teleconsulting Controlled before-after
study
Number of days hospitalized 180






Screening rate at due date 620
TLM-PATHOLOGY FROZEN
SECTION
Surgical patients Anatomic pathology operating theatre Tele-expertise Uncontrolled before-
after study
Time to perform the diagnostic test 224




Time to perform the diagnostic test 470
TLM-DERMATOLOGY Inmates Dermatology prison Teleconsulting Controlled before-after
study


















to French by two different persons speaking French
and English fluently, one back translation by another
English-speaking native, and then an expert committee
to validate the accuracy of the translation.
We created a registry of all patients refusing to use
telemedicine in order to assess acceptability by each
target population.
We will measure patient quality of life using the
French version of the EQ-5D questionnaire as well
as disease-specific quality of life instruments, where
appropriate.
5) Professional experience
All professionals using one of the telemedicine
applications will be requested to complete a
questionnaire of their perceptions regarding it. The
questionnaire is based on the MAST questionnaire
and was translated into French using the MAST
methodology. We will score each item using a
six-item Lickert scale.
Statistical analysis
Sample size calculations were made to demonstrate su-
periority (seven studies) or non inferiority (one study),
based on the estimated difference and standard deviation
(or on the estimated proportions) of the primary endpoint
between the groups (telemedicine versus usual care). We
used an alpha risk at 5 % and depending on the number of
patients potentially includible, we chose a beta risk at 10 %
or 20 %. The software used for calculation was found on
Statstodo Website [14].
Descriptive statistics (frequencies, means ± SD) will
be carried out by group, and subgroup analyses will be
performed when relevant.
For the RCTs, we will assess the effectiveness of tele-
medicine by using the intention-to-treat principle, with
the inclusion of all participants in the statistical analyses
regardless of whether they completed the intervention
or the follow-up measurements. Missing data will be
imputed using regression imputation techniques if the
population size and dataset allow it.
In the before-after studies with control groups, we will
perform differences-in-differences statistical tests.
For trials in which we anticipate censored data, for
example due to the high mortality risk of the specific
population, we will use the log-rank test. In addition, a
Cox proportional-hazards regression model will be used
to limit confounding factors.
Multivariate regression analyses will be used to assess
which institutional, clinical and demographic factors
predict the effect of telemedicine on outcomes.
Each item in the questionnaires of patient satisfaction
and health care professionals’ perceptions will be analysed
separately. No global scoring will be computed.
Discussion
The Paris Regional Health Agency telemedicine studies
are designed to evaluate the efficacy and cost-effectiveness
of an innovative regional policy in improving patient ac-
cess to care and outcomes compared to usual care in a
large population. The proposed study is to our knowledge
the first to explore the expected benefits of three different
types of telemedicine designed to address the needs of pa-
tients with chronic conditions and patients with limited
access to care.
Compared to published assessments of telemedicine
technologies ([8, 15]) using a single type of trial design
and uniform data collection, our studies may appear
fragmented and heterogeneous. However, the unifying
factor is that each features a comparative design combined
with the attempt of use of all relevant elements in the
matrix of endpoints and stakeholders.
One of the major lessons of our trial design exercise is
that evaluating telemedicine as a whole is not possible.
As Population, Intervention, Comparison, Outcome and
Time (The PICOT model [16]) are different in each project,
each intervention must be evaluated separately.
Another lesson is that telemedicine may require sig-
nificant changes within organizations, which may lead to
a lack of acceptability and thus require a long time be-
fore routine use is achieved. Indeed, the authors of the
MAST model point out that evaluation of a telemedicine
application should not be carried out until it is mature
[7]. This is a major consideration in interpreting results,
as a negative result may be due to weak project adherence
by the professionals involved.
Withdrawn designs
At the beginning of the trial design phase, we considered
designs other than individual RCT and before-after with
control group. For example, one attractive alternative
randomized design for public health interventions is the
stepped wedge design [17–19], which is particularly useful
when the intervention is thought to do more good than
harm and when it is impossible to implement the interven-
tion in half of all clusters simultaneously because of prac-
tical, logistical or financial reasons. In a stepped wedge
design, an intervention is rolled-out sequentially to the trial
participants (either individuals or clusters of individuals)
over a number of time periods. The order in which the in-
dividuals or clusters receive the intervention is determined
at random and, by the end of the random allocation, all
individuals or groups will have received the intervention.
We were unable, however, to randomize the sequence of
centers which had been previously decided by the funder
based on the equipment of facilities and the requirements
of the industrial partners.
Interrupted time series designs constitute a more
pragmatic approach to evaluating an innovation and
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are particularly relevant when the outcome is obtained
from routinely collected data [11] after implementation of
telemedicine, but also before, as statistical analyses rely on
the detection of a trend break. As the interventions are
still at the experimental stage, there is a learning curve,
and it is suggested that the users should be familiar with
the innovation before evaluating it. In practice, taking into
account the data collected earlier than 3–12 months
following implementation could provide false negative re-
sults. In our studies, use of this design was not possible as
no data were routinely collected before implementation.
Advantages and disadvantages of the proposed designs
Based on the results of the trials, the Paris Regional Health
Agency may propose widespread adoption. The primary
objective of this broad assessment program is to document
the potential benefits of telemedicine in very different
settings and across a wide range of end-users. Another
objective is to introduce the concept of evidence based
medicine in care settings in which its use has previously
been limited. Preliminary work on protocols underscored
the need for strong governance, staff training and system
redesign, including task shifting and cutting across bound-
aries and financial incentives.
Perspectives
Other telemedicine projects are pending and will be ana-
lyzed using the same framework: telemonitoring following
bariatric surgery, tele-expertise for neonate radiology,
teleconsulting for disabled children or individuals with
pervasive development disorders.
With the exception of the project “Teleconsulting and
rehabilitation at home after hip and knee surgical proce-
dures”, all projects described in the paper began including
patients as of December 2014. The first results are expected
by the end of 2015.
The Paris Regional Health Agency telemedicine studies
are still at an experimental phase, and future projects will
be focused on identifying which subgroups of patients
may benefit most from telemedicine.
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because the endpoint were the professional procedures and
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The ethics approval was given for TLM-HELP by the
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Endnote
1No. 2010–1229 Art.R. 6316–1 of 19 October 2010.
Abbreviations
HAS: Haute Autorité de Santé; MAST: Model for ASsessment of Telemedicine;
RCT: Randomized controlled trial; TLM: Telemedicine; WSD: Whole System
Demonstrator.
Competing interests
The authors declare that their institutions has received funding from or that
they are employees of the Paris Regional Health Authority.
Authors’ contributions
IDZ, NC and KZ drafted the manuscript and all other authors contributed to
editing of the final manuscript. DC, CG, MG, PJ, DK and FM are the Principal
Investigators of the studies. All authors read and approved the final manuscript.
Acknowledgments
The authors are deeply indebted to Ms Karen Berg Brigham (URC Eco Ile-de-
France (AP-HP), Paris, France) for her insightful comments on the manuscript.
ARS Telemedicine Group collaborators: Dr Valérie Bourdinaud, Hôpital Privé
Gériatrique les Magnolias, 77, rue Perray - 91160 Ballainvilliers. Dr Dominique
Copin, Fondation Santé Service, Pôle Rééducation- Handicap. 15 quai de
Dion Bouton, 92816 PUTEAUX. Pr Catherine Guettier, Service de Pathologie,
Hôpital Bicêtre APHP Faculte de médecine Bicêtre- Université Paris Sud. Dr
Michèle Granier, Service de réanimation néonatale, Centre Hospitalier Sud
Francilien. 116, Bd Jean Jaurès - 91100 Corbeil-Essonnes. Pr Patrick Jourdain,
Service de Cardiologie ambulatoire, Hôpital René DUBOS, 6 Avenue de l’Île
de France, 95300 Pontoise. Dr Daniel Kharat, Groupe ORPEA-CLINEA, 3, rue
Bellini, 92800 Puteaux – La Défense 11. Dr François Moreau, Centre Hospitalier
de Versailles, 177, rue de Versailles, 78150 LE CHESNAY.
Author details
1Faculty of Medicine, University Paris-Est, Créteil, France. 2ECEVE UMRS 1123,
Paris, France. 3Hôpital Hôtel Dieu, URC Eco Ile-de-France (AP-HP), 1 Place du
Parvis Notre Dame, 75004 Paris, France. 4Department of Public Health, Henri
Mondor-Albert Chenevier Hospitals (AP-HP), Créteil, France. 5ARS Ile de
France, Direction de la stratégie, pôle SI santé et innovations, Paris, France .
Received: 3 April 2015 Accepted: 22 January 2016
References
1. Oliveira TC, Branquinho MJ, Gonçalves L. State of the art in telemedicine -
concepts, management, monitoring and evaluation of the telemedicine
programme in Alentejo (Portugal). Stud Health Technol Inform. 2012;179:29–37.
2. Demaerschalk BM, Raman R, Ernstrom K, Meyer BC. Efficacy of telemedicine
for stroke: pooled analysis of the Stroke Team Remote Evaluation Using a
Digital Observation Camera (STRokE DOC) and STRokE DOC Arizona
telestroke trials. Telemed J E Health. 2012;18:230–7.
3. Maddry JK, Sessions D, Heard K, Lappan C, McManus J, Bebarta VS. Wartime
toxicology: evaluation of a military medical toxicology telemedicine consults
service to assist physicians serving overseas and in combat (2005–2012).
J Med Toxicol. 2014;10:261–5.
4. Harrison R, Clayton W, Wallace P. Can telemedicine be used to improve
communication between primary and secondary care? BMJ. 1996;313:1377–80.
discussion 1380–1381.
5. Drop SLS, Mure P-Y, Wood D, El-Ghoneimi A, Faisal Ahmed S. E-consultation
for DSD: a global platform for access to expert advice. J Pediatr Urol.
2012;8:629–32.
Charrier et al. BMC Health Services Research  (2016) 16:45 Page 7 of 8
6. Wynn R, Hagen K, Friborg O. Videoconferencing at a centre for rare disorders:
user satisfaction and user participation. Acta Paediatr. 2012;101:e83–85.
7. Kidholm K, Ekeland AG, Jensen LK, Rasmussen J, Pedersen CD, Bowes A,
et al. A model for assessment of telemedicine applications: mast. Int J
Technol Assess Health Care. 2012;28:44–51.
8. Steventon A, Bardsley M, Billings J, Dixon J, Doll H, Hirani S, et al. Whole
System Demonstrator Evaluation Team: Effect of telehealth on use of
secondary care and mortality: findings from the Whole System
Demonstrator cluster randomised trial. BMJ. 2012;344:e3874.
9. Haute Autorité de Santé - Efficience de la télémédecine : état des lieux de la
littérature internationale et cadre d’évaluation [http://www.has-sante.fr/portail/
jcms/c_1622477/fr/efficience-de-la-telemedecine-etat-des-lieux-de-la-litterature-
internationale-et-cadre-devaluation]
10. Mistry H, Garnvwa H, Oppong R. Critical appraisal of published systematic
reviews assessing the cost-effectiveness of telemedicine studies. Telemed
J E Health. 2014;20:609–18.
11. Sanson-Fisher RW, D’Este CA, Carey ML, Noble N, Paul CL. Evaluation of
systems-oriented public health interventions: alternative research designs.
Annu Rev Public Health. 2014;35:9–27.
12. Tubach F, Baron G, Falissard B, Logeart I, Dougados M, Bellamy N, et al.
Using patients’ and rheumatologists’ opinions to specify a short form of the
WOMAC function subscale. Ann Rheum Dis. 2005;64:75–9.
13. Newman S, Rixon L, Hirani S, Cartwright M, Beynon M, Cleanthous S, Selva
A: Quantifying beliefs regarding telehealth: development of the SUTAQ
service user technology acceptability questionnaire. 2011.
14. StatsToDo Home Page. https://www.statstodo.com/index.php. Accessed 29
December 2015.
15. Henderson C, Knapp M, Fernández J-L, Beecham J, Hirani SP, Cartwright M,
et al. Whole System Demonstrator evaluation team: Cost effectiveness of
telehealth for patients with long term conditions (Whole Systems
Demonstrator telehealth questionnaire study): nested economic evaluation
in a pragmatic, cluster randomised controlled trial. BMJ. 2013;346:f1035.
16. Riva JJ, Malik KMP, Burnie SJ, Endicott AR, Busse JW. What is your research
question? An introduction to the PICOT format for clinicians. J Can Chiropr
Assoc. 2012;56:167–71.
17. Brown CA, Lilford RJ. The stepped wedge trial design: a systematic review.
BMC Med Res Methodol. 2006;6:54.
18. Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster
randomized trials. Contemp Clin Trials. 2007;28:182–91.
19. Mdege ND, Man M-S, Taylor Nee Brown CA, Torgerson DJ. Systematic
review of stepped wedge cluster randomized trials shows that design is
particularly used to evaluate interventions during routine implementation.
J Clin Epidemiol. 2011;64:936–48.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Charrier et al. BMC Health Services Research  (2016) 16:45 Page 8 of 8
